↓ Skip to main content

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
12 patents

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
50 Mendeley
Title
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
Published in
Cancer Immunology, Immunotherapy, November 2003
DOI 10.1007/s00262-003-0429-0
Pubmed ID
Authors

Peter Hersey, Scott W. Menzies, Gary M. Halliday, Tam Nguyen, Margaret L. Farrelly, Chitra DeSilva, Margaret Lett

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 24%
Researcher 9 18%
Other 8 16%
Student > Master 4 8%
Student > Bachelor 4 8%
Other 5 10%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 16 32%
Agricultural and Biological Sciences 13 26%
Immunology and Microbiology 7 14%
Nursing and Health Professions 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 8%
Unknown 8 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#3,798,066
of 25,371,288 outputs
Outputs from Cancer Immunology, Immunotherapy
#273
of 2,982 outputs
Outputs of similar age
#5,979
of 57,674 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 21 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,674 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.